Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Editas Medicine Inc’s recent filing unveils that its SVP, Chief Financial Officer Parison Amy unloaded Company’s shares for reported $769.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Editas Medicine Inc’s filing revealed that its EVP, CHIEF FINANCIAL OFFICER Lucera Erick unloaded Company’s shares for reported $7030.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Editas Medicine Inc’s recent filing unveils that its EVP, CHIEF FINANCIAL OFFICER Lucera Erick unloaded Company’s shares for reported $7030.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or